Cargando…
Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer
We report three signatures produced from SHARPIN gene copy number increase (GCN-Increase) and their effects on patients with breast cancer (BC). In the Metabric dataset (n = 2059, cBioPortal), SHARPIN GCN-Increase occurs preferentially or mutual exclusively with mutations in TP53, PIK3CA, and CDH1....
Autores principales: | Ojo, Diane, Seliman, Maryam, Tang, Damu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582379/ https://www.ncbi.nlm.nih.gov/pubmed/28879097 http://dx.doi.org/10.1016/j.bbacli.2017.07.004 |
Ejemplares similares
-
Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk
por: De Melo, Jason, et al.
Publicado: (2015) -
Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis
por: Cummings, M C, et al.
Publicado: (2000) -
Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system
por: Miao, Jinxin, et al.
Publicado: (2022) -
Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
por: Silveira, Sara Martoreli, et al.
Publicado: (2013) -
SHARPIN Facilitates p53 Degradation in Breast Cancer Cells()()
por: Yang, Huijie, et al.
Publicado: (2017)